Literature DB >> 14734629

Type 2 diabetes mellitus: not quite exciting enough?

Frances Ashcroft1, Patrik Rorsman.   

Abstract

Type 2 diabetes mellitus is a serious metabolic disease that afflicts around 5% of the population in Western societies and over 150 million people worldwide. It is characterized by elevation of the blood glucose concentration, usually presents in middle age, and is exacerbated by obesity. Both genetic and environmental factors contribute to the disease but in the vast majority of cases the aetiology is still not understood. Here we present a novel hypothesis for the aetiology of type 2 diabetes. We postulate that the electrical activity of the insulin-secreting beta-cells of the pancreas acts to integrate the genetic and environmental factors that predispose to disease risk. Our hypothesis is supported by a substantial amount of data gathered from a range of different disciplines and makes predictions that can be tested experimentally both in vitro and in man.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14734629     DOI: 10.1093/hmg/ddh066

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  25 in total

1.  Exocytosis from pancreatic β-cells: mathematical modelling of the exit of low-molecular-weight granule content.

Authors:  Juris Galvanovskis; Matthias Braun; Patrik Rorsman
Journal:  Interface Focus       Date:  2010-12-08       Impact factor: 3.906

2.  A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.

Authors:  Shay Eliahu; Haim M Barr; Jean Camden; Gary A Weisman; Bilha Fischer
Journal:  J Med Chem       Date:  2010-03-25       Impact factor: 7.446

Review 3.  ATP-sensitive potassium channelopathies: focus on insulin secretion.

Authors:  Frances M Ashcroft
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

4.  Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.

Authors:  Paolo Tammaro; Christophe Girard; Janne Molnes; Pål R Njølstad; Frances M Ashcroft
Journal:  EMBO J       Date:  2005-06-16       Impact factor: 11.598

5.  A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.

Authors:  P Tammaro; S E Flanagan; B Zadek; S Srinivasan; H Woodhead; S Hameed; I Klimes; A T Hattersley; S Ellard; F M Ashcroft
Journal:  Diabetologia       Date:  2008-03-12       Impact factor: 10.122

6.  Differential Expression of Metabolism-related Genes in Liver of Diabetic Obese Rats.

Authors:  Eunhui Seo; Eun-Jin Park; Mi-Kyoung Park; Duk Kyu Kim; Hye-Jeong Lee; Sook-Hee Hong
Journal:  Korean J Physiol Pharmacol       Date:  2010-04-30       Impact factor: 2.016

7.  Purinergic receptors in the endocrine and exocrine pancreas.

Authors:  I Novak
Journal:  Purinergic Signal       Date:  2007-12-11       Impact factor: 3.765

Review 8.  New insights concerning the molecular basis for defective glucoregulation in soluble adenylyl cyclase knockout mice.

Authors:  George G Holz; Colin A Leech; Oleg G Chepurny
Journal:  Biochim Biophys Acta       Date:  2014-06-27

9.  A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome.

Authors:  Peter Proks; Christophe Girard; Shozeb Haider; Anna L Gloyn; Andrew T Hattersley; Mark S P Sansom; Frances M Ashcroft
Journal:  EMBO Rep       Date:  2005-05       Impact factor: 8.807

10.  Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

Authors:  Laerke Egefjord; Jens Ledet Jensen; Claus Heiner Bang-Berthelsen; Andreas Brønden Petersen; Kamille Smidt; Ole Schmitz; Allan Ertman Karlsen; Flemming Pociot; Fabrice Chimienti; Jørgen Rungby; Nils E Magnusson
Journal:  BMC Endocr Disord       Date:  2009-02-25       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.